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Abstract
Intravascular photoacoustic-ultrasound (IVPA-US) imaging and near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS) are
two hybrid modalities that detect arterial lipid, with comparison necessary to understand the relative advantages of each.We performed
in vivo and ex vivo IVPA-US imaging of the iliac arteries of Ossabaw swine with metabolic syndrome (MetS) and lean swine to
investigate sensitivity for early-stage atherosclerosis. We repeated imaging ex vivo with NIRS-IVUS for comparison to IVPA-US and
histology. Both modalities showed significantly greater lipid in MetS vs. lean swine, but only IVPA-US localized the lipid as
perivascular. To investigate late-stage atherosclerosis, we performed ex vivo IVPA-US imaging of a human coronary artery with
comparison to NIRS-IVUS and histology. Two advanced fibroatheromas were identified, with agreement between IVPA-measured
lipid area andNIRS-derived lipid content. As confirmed histologically, IVPA-US has sensitivity to detect lipid content similar to NIRS-
IVUS and provides additional depth resolution, enabling quantification and localization of lipid cores within plaques.
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Introduction
Over the past two decades, morphometric data from autopsy
specimens have advanced our understanding of atherosclerotic
plaque types and their progression to major adverse cardiovas-
cular events [1, 2]. Evidence has shown that thin-capped
fibroatheromas (TCFAs) are the plaque type most vulnerable
to rupture and are defined by hallmarks of a thin fibrous cap, a
large lipid-rich necrotic core, and inflammatory infiltrate [3–5].
Development of intravascular imaging tools to detect vulnera-
ble plaques has been the focus of intense investigation, yet none
have been shown to reliably identify TCFAs. Detection of vul-
nerable plaques will be instrumental in elucidating the mecha-
nisms underlying lesion progression, the development of pre-
ventive and therapeutic interventions, and ultimately, reducing
CAD-related morbidity and mortality [6–9].
Current intravascular imaging modalities aim to detect hall-
marks of TCFAs as a marker of vulnerability. For example,
near-infrared spectroscopy (NIRS) uses broadband light ab-
sorption to identify lipid-rich plaque and is complemented with
intravascular ultrasound (IVUS), which has long been used
independently to image vessel and plaque morphology only.
The NIRS-IVUS hybrid modality has been successfully vali-
dated against histopathology to identify lipid-rich plaques, dif-
ferentiate between culprit and non-culprit segments, and rea-
sonably predict cardiovascular outcomes in CAD patients
[10–14]. Yet, NIRS-IVUS is limited by lack of depth (or radial)
resolution, distinguishing only where vascular lipid is
circumferentially. This modality cannot provide information
about the dimensions of lipid deposition, which is necessary
for optimally assessing vulnerability, monitoring lesion pro-
gression, and pathophysiological involvement of arterial lipids.
Intravascular photoacoustic (IVPA) imaging has been the
latest addition to the list of modalities and uses ultrasound-
based detection of optical absorption as a means of contrast.
Photoacoustic (PA) imaging relies on the principle that small
absorbance of light by C-H bonds abundant in lipids cause
thermoelastic expansion and generation of detectable acoustic
waves. As a result, IVPA imaging benefits from both optical-
and acoustic-based modalities: label-free chemical selectivity
and ample penetration depth [15–18]. In IVPA catheters, the
optical fiber and ultrasound (US) transducer have been mini-
aturized to fit and examine overlapping fields of view
[19–22]. Thus, IVPA-US operates inherently as a hybrid in-
travascular catheter, capable of producing complementary
cross-sectional images of vascular morphologic information
and depth-resolved, lipid-specific compositional information
via US and PA channels, respectively [23–25]. IVPA-US im-
aging has moved towards clinical translation, as limitations
such as image acquisition speed and co-registration of chan-
nels have been addressed in recent years [20–22, 26, 27]. Yet,
there remain significant limitations. For instance, while IVPA-
US imaging has been shown to be feasible through blood,
optimal sensitivity is still achieved with blood clearance or
dilution with saline heavy water (D2O) [20, 22].
As both IVPA-US and NIRS-IVUS detect the lipid-rich
component contributing to a vulnerable plaque phenotype,
comparison between the two hybrid modalities is warranted.
Our aim was to elucidate the relative advantages and short-
comings of each modality.
Here, we demonstrate the ability of in vivo and ex vivo
IVPA-US imaging to quantify increased perivascular adipose
tissue (PVAT), a known mediator of early atherosclerotic plaque
formation, using Ossabaw miniature swine, a previously char-
acterized large animal model of metabolic syndrome (MetS) and
dyslipidemia [28–31].We further compare IVPA-US imaging to
ex vivo NIRS-IVUS and histopathology. The ability to detect
and localize arterial lipids in early atherosclerosis will provide
insights into the role of PVAT in lesion progression. This mech-
anism involves Boutside-to-inside^ signaling from PVAT-
derived adipokines (e.g., leptin) that diffuse to the vascular wall
and synergize with more classical Binside-to-outside^mediators
(e.g., lipoproteins) to promote atherosclerosis [28–31].
Furthermore, we show comparative quantification and localiza-
tion of advanced atherosclerotic plaques in a fresh human coro-
nary artery by ex vivo IVPA-US compared to NIRS-IVUS and
histopathology. To our knowledge, this is the first comparison of
IVPA-US to NIRS-IVUS imaging, and other existing modali-
ties, such as single-modality grayscale IVUS.
Materials and Methods
Animal Care and Use
Ossabaw miniature swine (n = 3) were maintained to meet the
characteristics of MetS for 8 months. For 7 of 8 months, they
were fed a hypercaloric, atherogenic diet (1 kg/day) and were
approximately age 16months at euthanasia. For a lean control,
a subset of swine (n = 2) were fed a standard chow diet
(0.7 kg/day). Metabolic data including body weight, blood
pressure, serum chemistry, and plasma lipids were collected
to confirm development of MetS and dyslipidemia.
Development of MetS and preclinical vascular disease in this
naturally progressive animal model of human disease has been
characterized extensively in previous work [32, 33].
Anesthesia was induced via intramuscular injection of
telazol (5–6 mg/kg) and xylazine (2.2 mg/kg), and maintained
with 2–4% isoflurane mixed with 100% oxygen.
IVPA-US Imaging System and Catheter
The high-speed IVPA-US imaging system used in this work
has been described in detail elsewhere [21, 22, 27]. Briefly, a
nanosecond Nd:YAG pumped optical parametric oscillator
excitation laser source emitting at 1730 nm with a 2-kHz
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repetition rate was used for photoacoustic excitation. A col-
linear catheter with a 42-MHz transducer was used for all
swine imaging (Fig. 1a). For human coronary artery imaging,
a modified quasi-collinear probe design was used, in which
angling of the transducer and reduction of reflection surfaces
maintained optical and acoustic co-registration and improved
US quality (supplementary Fig. S1) [22]. The laser pulse en-
ergy delivered to the tissue was controlled to a fluence of
50 mJ/cm2, below the ANSI laser safety standard for of 1 J/
cm2 at 1730 nm for the skin. The catheter was enclosed within
a protective sheath composed of polyurethane and had an
outer diameter of 1.6 mm. For all IVPA-US imaging, the cath-
eter sheath was flushed with deuterium oxide (D2O) due to
decreased optical absorption compared to H2O.
In vivo Imaging: Angiography, IVUS, and IVPA-US
A 7-Fr introducer sheath was inserted in the right femoral
artery of swine and heparin was administered (50 U/kg).
Next, a 7-Fr guiding catheter was advanced to access the right
iliac artery, through which our 4.8-Fr, 42-MHz hybrid IVPA-
US catheter was advanced 80 mm distally and two automated
pullbacks were recorded at 0.5 mm/s and 8 frames per second
(fps) imaging speed (Fig. 1b–d). Next, a 3.2-Fr, 45-MHz sin-
gle-modality grayscale IVUS catheter (Revolution, Volcano,
Corp.) was advanced 80 mm distally and a pullback was re-
corded at 0.5 mm/s and 30 fps. In one lean control animal,
right and left iliac arteries were both imaged. All in vivo
imaging was performed through luminal blood, without clear-
ance or dilution. Following imaging, the animals were euthan-
atized by isoflurane overdose and cardiectomy.
Ossabaw Swine Tissue Recovery and Preparation
Following euthanasia, the iliac artery was isolated, marked
with a suture knot 80 mm distal to the guiding catheter, and
dissected out of the animal. Side branches and the distal end
were ligated with suture for pressure-perfusion during ex vivo
imaging, followed by formalin fixation.
Human Tissue Recovery and Preparation
A fresh human heart was harvested from a 59-year-old male
undergoing transplant surgery, within 24 h of explant. The
patient had coronary heart disease risk factors of smoking,
hypertension, and obesity. The right coronary artery was ex-
cised, the ostium was cannulated with a 6-Fr introducer
sheath, and side branches and the distal end of the artery were
ligated with suture for pressure-perfusion. Artery anatomy
was observed by ex vivo angiography. All imaging was per-
formed within 48 h of dissection.
Ex vivo Imaging: IVPA-US and NIRS-IVUS
The hybrid IVPA-US catheter was advanced to the 80-mm
mark of Ossabaw iliac artery segments and perfused with
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aFig. 1 IVPA-US imaging probeand in vivo imaging procedure. a
Schematic of the IVPA-US
collinear catheter design, in which
the acoustic and optical paths
overlap, after a series of
reflections off the rod mirror and
optical fiber surfaces. b
Schematic of the in vivo
procedure, in which the IVPA-US
catheter was advanced 80 mm
into the iliac artery of swine. c
Angiogram with contrast to
visualize vascular anatomy. d
Angiogram without contrast to
confirm IVPA-US catheter
placement at 80 mm distal to the
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1X phosphate buffered saline at approximately 70 mL/min,
during which an automated pullback was recorded at
0.25 mm/s and 4fps imaging speed. This procedure was
repeated with a 3.2-Fr, 40-MHz hybrid NIRS-IVUS catheter
(TVC Insight, Infraredx, Inc.) with a 0.5-mm/s pullback
speed and 16 fps imaging speed. Human coronary artery
imaging was performed following the same protocol, with
the pullbacks starting approximately 70 mm distal to the
introducer sheath.
IVPA-US and NIRS-IVUS Quantitative Analysis
To compare pullbacks from two hybrid modalities collected
with different optimal frame rates and pullback speeds, we
used angiography and landmarks, such as the introducer
sheath and fiduciary side branches, to align frames.
IVPA-US imaging data were post-processed to reduce
noise and pixels at which PA intensity was greater than a set
threshold were counted per cross-sectional frame to calculate
lipid area (four times the background noise for all ex vivo data
sets and five times the background noise for all in vivo data
sets). Thresholds were determined by an investigator blind to
sample group, other imaging results, and histology. For hu-
man coronary artery imaging, the lipid core volume was cal-
culated per lesion within a 4-mm segment by identifying
depth and angle boundaries within which pixels were counted.
All lipid area measurements were calculated using MATLAB
software (MathWorks, Inc.).
Cross-sectional lipid areas were binned and averaged for
correlation analysis between repeat in vivo and ex vivo
pullbacks to assess reproducibility of data.
The NIRS-IVUS TVC Insight system was used to generate
two-dimensional Bchemograms^ representing probability of
the presence of lipid by a yellow color, with longitudinal pull-
back position on the x-axis and circumferential position on the
y-axis. As NIRS-IVUS spectral depth is 1 mm or less, lipid
area was estimated by measuring the yellow-colored regions
on the 2D chemograms. The system also generated Bblock
chemograms,^ representing the artery in 2-mm segments with
discrete colorized representation of the probability of lipid
present. We defined blocks colored red as having no lipid
present (p < 0.57) and all other colors as having increased
probability of lipid present [34]. The total lipid core burden
index (LCBI) and maximum LCBI within a 4-mm segment
(maxLCBI4mm) were also calculated by the system.
Calcification was measured from the IVUS channel of the
hybrid modalities and defined as strong echogenicity with
acoustic shadowing. The total length was calculated as con-
tinuous frames in which calcification was present and maxi-
mum arc was calculated as the largest angle of acoustic
shadowing. All analysis of the IVUS channel was performed
using ImageJ software (National Institutes of Health).
Histological Preparation and Analysis
Imaged arteries were pressure-fixed using 10% w/v formalin
and placed in formalin overnight. Contralateral control iliac
arteries from Ossabaw swine were not pressure-fixed. Arteries
were then grossly sectioned in 3- to 4-mm segments. Next, all
segments were paraffin embedded, thin sectioned, and stained
with hematoxylin and eosin (H&E) and Verhoeff-Van Gieson
elastin stain. In the human coronary artery with advanced ath-
erosclerosis, Russel-Movat’s pentachrome stain was used to
identify and characterize lipid core plaques [1, 10]. Lipid-rich
necrotic cores were defined as morphologically distinct empty
and/or clear, granular, mostly anucleate spaces, defined as the
light-microscopic characteristics of lipid gruel, with macro-
phage infiltration, cholesterol clefts, or calcification [1, 2, 35].
Necrotic core area was calculated using ImageJ software.
Statistics
All data are described as mean ± SEM. Statistical significance
was set a priori at p < 0.05. Unpaired, two-tailed Student’s t
tests, Fisher’s exact test, and Pearson’s correlation were used
as appropriate using GraphPad Prism statistical software
(GraphPad Software, Inc.).
Results
IVPA-US Sensitivity for Early-Stage Atherosclerosis
in Ossabaw Swine
Ossabaw swine on hypercaloric, atherogenic diet developed
the characteristics of MetS, including significantly greater to-
tal cholesterol, triglycerides, and weight at sacrifice compared
to swine in the lean control group (Table 1). Despite the de-
velopment of MetS in swine, on in vivo and ex vivo iliac
artery imaging of both groups, no significant intimal lipid
deposition was detected on all modalities, consistent with his-
tology which showed mild vascular disease evident as mini-
mal neointimal hyperplasia (Fig. 2).
Table 1 Metabolic characteristics of Ossabaw swine
Lean (n = 2) MetS (n = 3) p value
Sex (M/F) 1/1 0/3 N/A
Weight at sacrifice (kg) 50.5 ± 10.5 95.0 ± 1.5* 0.01
Mean weight gain (kg) 31.0 58.7 ± 3.0 N/A
Plasmalipids
Cholesterol (mg/dL) 71 ± 12 465 ± 53* 0.01
Triglycerides (mg/dL) 26 ± 2 63 ± 4* 0.01
*p < 0.05
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However, in specific segments of the iliac arteries, low
levels of lipid signal were detected by both IVPA-IVUS and
NIRS-IVUS, which were further localized to the perivascular
region and confirmed as PVAT by histology (Fig. 3). Similar
signal was detected by NIRS-IVUS at corresponding regions
of interest, albeit without localization of the lipid depot radi-
ally due to lack of depth resolution (Fig. 3d).
On in vivo IVPA imaging, we found that the average cross-
sectional lipid area was significantly greater in the iliac arteries
of swine with MetS as compared to lean swine (0.089 ±
0.016 mm2 vs. 0.059 ± 0.001 mm2; p < 0.0001) (Fig. 4a).
These results were also observed on ex vivo imaging (0.032
± 0.001 mm2 vs. 0.005 ± 0.0002 mm2; p < 0.0001) (Fig. 4b).
Correlation of IVPA-US with NIRS-IVUS in Early-Stage
Atherosclerosis
On ex vivo NIRS-IVUS imaging, we found similar results to
IVPA-US imaging, as arteries of swine with MetS had signif-
icantly more 2-mm block chemograms with increased proba-
bility of lipid present than arteries of lean swine (8/117 blocks
with lipid vs. 0/80 blocks with lipid; p = 0.02). Taken together,
these results conclude IVPA-US is comparable to NIRS-IVUS
in sensitivity for the detection of increased lipid content.
Furthermore, depth resolution of IVPA-US imaging allowed
localization of lipid deposition to PVAT, a known mediator of
early atherogenesis [28–31].
IVPA-US Imaging In vivo Safety and Reproducibility
We evaluated the safety of the in vivo imaging procedure and
reproducibility of our results. On angiography, we did not
observe significant vasospasm after IVPA-US pullback (sup-
plementary Fig. S2a-b). On histology, we did not observe any
significant damage to the internal elastic lamina of imaged
arteries compared to contralateral control arteries (supplemen-
tary Fig. S2c-f). Additionally, in three swine iliac arteries, we
performed repeat in vivo pullbacks and there was significant
correlation of lipid area between pullbacks (p < 0.0001 for all
data sets) (supplementary Fig. S3). In a MetS-group swine
iliac artery, we further compared lipid area measures from
in vivo pullbacks with ex vivo pullback data and we also
found significant correlation (p < 0.05 for all data sets)
(supplementary Fig. S4).
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Fig. 2 Representative imaging and histology from a MetS Ossabaw swine
iliac artery showing no intimal lipid deposition and only early-stage
neointimal thickening. a In vivo IVPA-US still frame, in which no lipid
deposition (absence of red) and mild neointimal hyperplasia (three-layer
appearance, grayscale IVUS channel) was observed. b In vivo single-
modality grayscale IVUS still frame, depicting the three-layer appearance.
c Ex vivo IVPA-US still frame, in which no lipid deposition and the three-
layer appearance were observed. d Ex vivo NIRS-IVUS still frame, in
which no lipid deposition (absence of yellow circumferentially) and the
three-layer appearance (grayscale IVUS channel) were observed. e
Verhoeff–Van Gieson stained histological section, showing typical artery
morphology with a small area of neointimal thickening (NEO) on the
luminal side of the internal elastic lamina (IEL). M media, A adventitia.
Horizontal and vertical axis tracings are 1 mm apart
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IVPA-US Sensitivity for Late-Stage Atherosclerosis
in a Human Coronary Artery
On ex vivo imaging of a fresh human right coronary with
atherosclerosis, we identified two advanced fibroatheromas
with calcification on both IVPA-US and NIRS-IVUS
(Fig. 5). We defined the atheroma proximal to the introducer
sheath as lesion 1 and the distal atheroma as lesion 2 (Table 2).
On both hybrid modalities, calcification was evident on
ultrasound by strong echogenicity with acoustic shadowing
(Fig. 5b, c, panels III and IV). Furthermore, lipid was present
as indicated by yellow color on the circumferential chemogram
by NIRS-IVUS and red color on cross-sectional images by
IVPA-US. Characterization of the atherosclerotic features in
both lesions were confirmed by histopathology (Fig. 3d).
On IVPA-US imaging, we calculated the average cross-
sectional lipid area within a 4-mm segment for both lesions.
Lesion 1 had an average lipid area of 0.15 ± 0.004 mm2 (range
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Fig. 3 Representative in vivo IVPA-US imaging from a MetS Ossabaw
swine iliac artery showing a lipid signal by both modalities. a Unmerged
IVUS channel still frame showing a three-layer appearance of the iliac
artery. b Unmerged IVPA channel still frame showing circumferential
distribution and depth of lipid signal (red). c Merged composite
showing depth-resolved lipid signal localized to the perivascular region.
d NIRS-IVUS still frame showing grayscale IVUS channel and lipid
signal (yellow) circumferentially, but not the precise radial depth into
the arterial wall and perivascular regions. e Verhoeff–Van Gieson
stained histological section showing abundant perivascular adipose
tissue (PVAT, inset), noted by the presence of round and empty
adipocytes. I intima, M media, A adventitia. Horizontal and vertical
axis tracings are 1 mm apart
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Fig. 4 Average cross-sectional lipid area in iliac arteries as determined by
IVPA-US imaging. The average cross-sectional lipid area, as calculated
by photoacoustic signal intensity per frame above a pre-determined
threshold, is significantly greater in the iliac arteries of swine with MetS
as compared to lean swine, both by in vivo (a) and ex vivo (b) imaging;
*** p < 0.0001; n refers to number of cross-sectional frames analyzed
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0.08–0.24) and lesion 2 had an average lipid area of 0.40 ±
0.03 mm2 (range 0.04–1.04). Particularly, lesion 2, within the
measured 4-mm segment, had a significantly greater average
lipid area than the remaining length of artery (0.40 mm2 vs.
0.26 mm2; p < 0.0001). We further measured the total lipid
area within a 4-mm segment for each lesion (lesion 1
9.57 mm2, lesion 2 25.95 mm2).
Lastly, depth resolution and co-registered imaging allowed
us to identify the contiguous lipid areas adjacent to calcifica-
tion as the plaque lipid core and calculated the volumes as
0.11 mm3 and 0.25 mm3 for lesions 1 and 2, respectively.
Relation of the plaque lipid core to calcification and the lumen
border is further illustrated by three-dimensional reconstruc-
tion of the 4-mm segments (supplementary Videos 1 and 2).
Correlation of IVPA-US with NIRS-IVUS and Histology
in Late-Stage Atherosclerosis
Quantifications by IVPA-US imaging were in agreement
with similar measures made by NIRS-IVUS imaging and
histopathology. On NIRS-IVUS, we found lesion 2 to
have a high maxLCBI4mm value of 326, consistent with
the large lipid area and core volume measured by IVPA-
US. No maxLCBI4mm was calculated for lesion 1 due to
lack of sufficient spectrally valid pixels. Using the gener-
ated chemogram, we approximated lipid areas as
5.22 mm2 for lesion 1 and 26.38 mm2 for lesions 2, com-
parable to the values measured by IVPA-US.
In addition, we characterized the calcification in both le-
sions by measuring the total length and maximal arc of calci-
fication, as shown in Table 2. Both IVPA-US and NIRS-IVUS
systems showed similar values, demonstrating comparable
resolution of the US channel for the identification of
calcification.
Lastly, on histopathology we measured histologic necrotic
core areas of 0.42 mm2 and 1.36 mm2 for lesions 1 and 2,
respectively. The larger necrotic core area on histopathology
compared to the average cross-sectional lipid area by IVPA-
US was anticipated, as necrotic cores contained features such
as prominent calcification, in addition to lipid.
Comparative imaging by two hybrid modalities and gold-
standard histopathology confirm that depth-resolved IVPA-
US has the capability to quantify and localize plaque lipid
cores with calcification.
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Fig. 5 Correlation between modalities in a fresh human coronary artery. a
Ex vivo angiogram of the artery, in which the sheath (I), side branches (II,
V), and lesions locations (III, IV) are identified. Location III refers to
Lesion 1 and location IV to Lesion 2. b, c Corresponding cross-
sectional still frames are shown from NIRS-IVUS (b) in which lipid is
shown with yellow and from IVPA-US (c) in which lipid is represented
by red. Notable side branches are indicated by arrowheads and
calcification by arrows. d Movat’s pentachrome stained histological
sections of lipid core lesions (*) with calcification (arrows). Horizontal
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Discussion
Previous studies using NIRS-IVUS clearly show the clinical
value of identification of arterial lipid as a prognostic indicator
of cardiovascular outcomes [12–14]. Those preliminary studies
support the notion that accurate detection of arterial lipid content
by a reliable intravascular imaging modality, or combination of
multiple modalities, could be predictive of lesions at high risk to
progress to cardiovascular events. Multiple prospective studies,
including PROSPECT II ABSORB sub-study (NCT02171065)
and the Lipid-Rich Plaque Study (NCT02033694), aim to an-
swer this important question [36]. As the only FDA-approved
device for measuring lipid-rich plaques, NIRS-IVUS undoubt-
edly has great promise in clinical practice. Yet, lack of depth
resolution limits quantitative imaging of lipid and relies upon
LCBI as a derived measure to distinguish between high-risk and
low-risk plaques. In other words, NIRS-IVUS provides an ex-
cellent biochemical assay of bulk lipid content in sections of
artery, but the precise location of lipid in the vascular wall and
perivascular compartment is not provided.
Here, we conducted the first head-to-head comparison of
IVPA-US to NIRS-IVUS and highlight the value of depth
resolution in lipid detection. We have demonstrated the capa-
bility of IVPA-US to detect both superficial and deep lipid,
i.e., lipid within an advanced plaque core and perivascular
lipid of early-stage atherosclerosis.
By ex vivo imaging of a human coronary artery, we iden-
tified advanced lipid core plaques by both NIRS-IVUS and
IVPA-US. We were able to quantify and localize the lipid at
corresponding lesions using IVPA-US only, by virtue of depth
resolution with co-registration of the two modalities. A dem-
onstrated advantage with depth-resolved lipid imaging is vol-
umetric quantification of lipid plaque cores, which would per-
mit more accurate longitudinal studies monitoring plaque pro-
gression and regression. Alterations in plaque morphology
and composition could be more meaningful with visualization
of lipid core dimensions and relation to other plaque compo-
nents (i.e., fibrous cap, calcification). This would aid in
elucidation of the prevalence and mechanisms of plaque de-
velopment, stability, and rupture [37].
Additionally, by in vivo IVPA-US imaging of iliac arteries,
we detected early-stage atherosclerotic changes in the form of
increased PVAT inOssabaw swinewithMetS versus lean swine.
Intravascular catheter detection of PVAT, although not consid-
ered vulnerable pathology, would be a valuable measure to in-
vestigate its role in early atherogenesis. Many groups have ob-
served an enhanced pro-inflammatory milieu in adipose tissue
of patients with CAD versus those without disease, supporting
the hypothesis that PVATexerts paracrine stimulation of athero-
genesis in an Boutside-to-inside^ manner [28, 38]. In cross-
sectional clinical studies, PVAT quantity is strongly associated
with several atherosclerotic measures, including plaque pres-
ence, percent coronary artery stenosis, coronary artery calcium
score, and future major adverse cardiovascular events [29, 30].
Lastly, surgical resection of local coronary PVAT in swine
models has been shown to attenuate underlying coronary ath-
erosclerosis, providing the first causal evidence [31]. However,
PVAT is traditionally measured by computed tomography along
the cardiac short axis and co-localization to intravascular mea-
sures such as plaque burden are not possible, limiting the ability
to assess the causal relationship. In other words, the field cur-
rently does not have the tools necessary to answer the question:
do local depots of PVAT precede the development of underlying
atherosclerosis? This shortcoming can be addressed by IVPA-
US, which has penetration depths of up to 6 mm and can image
plaque burden and PVAT in one procedure, enabling needed
longitudinal natural history studies [21].
Lastly, clinical translation of IVPA-US will require valida-
tion against a robust data set of human histopathology conduct-
ed ex vivo [10]. Here, we have shown evidence in swine dem-
onstrating correlation between ex vivo imaging through saline
and in vivo imaging through blood. Additionally, we have con-
firmed safety of our in vivo procedure, in which there were no
peri-procedural complications. Lastly, we observed no irritation
to the artery as indicated by insignificant post-pullback vaso-
spasm and no disruption to the internal elastic lamina.
Table 2 Comparison of lesion
characteristics from ex vivo
imaging of a human right
coronary artery by NIRS-IVUS
and IVPA-US
Lesion 1 (proximal) Lesion 2 (distal)
NIRS-IVUS measured lesion characteristics
maxLCBI4mm N/A 326
Total lipid area (mm2) 5.22 26.38
Total calcified length (mm) 3.1 2.0
Maximum arc of calcification (o) 46.2 66.7
IVPA-US measured lesion characteristics
Average lipid area4mm (mm
2) 0.15 ± 0.004 0.40 ± 0.03
Total lipid area4mm (mm
2) 9.57 25.95
Lesion lipid core volume (mm3) 0.11 0.25
Total calcified length (mm) 3.4 2.4
Maximum arc of calcification (o) 58.1 66.4
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This study is limited by the lack of intimal lipid in the iliac
arteries of Ossabaw swine and subsequent absence of analysis
for correlation of in vivo neointimal lipid imaging to histopa-
thology. The observation of increased PVAT depots, no neo-
intimal lipid, and mild neointimal thickening is very intriguing
and could provide new insights about atherogenesis. In future
studies, we intend to employ longer durationMetS phenotypic
development and longitudinal IVPA-US imaging to determine
whether increased PVAT precedes an increase in neointimal
lipid. We will also address catheter size and flexibility limita-
tions to image coronary arteries, in which atherosclerotic dis-
ease develops more predictably [32].
Lastly, our human artery sample size is small and does not
include a wide range of atherosclerotic plaque phenotypes. Thus,
wewere unable to calibrate our thresholding algorithm for IVPA-
derived lipid area to correlate with histopathological lipid-rich
necrotic core area. We intend to build a larger calibration data
set to address this limitation. In addition, we anticipate future
application of spectral algorithms to differentiate between cho-
lesterol subtypes, as a surrogate marker of inflammation [39].
Conclusion
As intravascular imagingmodalities for lipid imaging advance in
capability and combination with others, comparison between
systems will be instrumental in determining the relative advan-
tages and disadvantages of each. We have demonstrated detec-
tion of increased lipid deposition in Ossabaw swine with early-
stage atherosclerosis versus lean swine by IVPA-US imaging, in
agreement with NIRS-IVUS imaging of the same specimens.
Further, we have shown detection of late-stage atherosclerotic
plaques in human coronary arteries by both modalities. In
conducting this comparison, we reveal the advantage of depth-
resolved IVPA-US imaging in varying stages of atherosclerosis
for the localization and quantification of both superficial and
deep lipid content, even extending into the perivascular region.
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